Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their In Silico Characterization
Authors:
- 1 May 2021
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 28 (5) , 508-519
Abstract
Aim: To identify and characterize peptide binders to truncated recombinant chikungunya virus envelope protein 2. Background: Despite extensive research on the chikungunya virus (CHIKV), the specific antiviral treatment’s unavailability has stressed the need for the urgent development of therapeutics. The Envelope protein 2 (E2) of CHIKV that displays putative receptor binding sites and specific epitopes for virus neutralizing antibodies is a critical target for the therapeutic intervention. Objective: The study aims to identify the unique peptides that can bind to truncated E2 protein of CHIKV and further explore their properties as potential therapeutic candidate. Methods: A stretch of CHIKV-E2 (rE2), which is prominently exposed on the surface of virion, was used as bait protein to identify peptide binders to the CHIKV-rE2 using a 12-mer phage display peptide library. Three rounds of biopanning yielded several peptide binders to CHIKV-rE2 and their binding affinities were compared by phage ELISA. Additionally, a fully flexible-blind docking simulation investigated the possible binding modes of the selected peptides. Furthermore, the selected peptides were characterized and their ADMET properties were explored in silico. Results: Five peptides were identified as potential binders based on their robust reactivity to the bait protein. The selected peptides appeared to interact with the crucial residues that were notably exposed on the surface of E1-E2 trimeric structure. The explored in silico studies suggested their non-allergenicity, non-toxicity and likeliness to be antiviral. Conclusion: The potential binding peptides of CHIKV-rE2 protein were identified using phage display technology and characterized in silico. The selected peptides could be further used for the development of therapeutics against the CHIKV infection.Keywords
Funding Information
- Department of Science and Technology (DST-INSPIRE (IF 150104))
This publication has 40 references indexed in Scilit:
- In Silico Approach for Predicting Toxicity of Peptides and ProteinsPLOS ONE, 2013
- Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya VirusPLOS Pathogens, 2013
- admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET PropertiesJournal of Chemical Information and Modeling, 2012
- AVPpred: collection and prediction of highly effective antiviral peptidesNucleic Acids Research, 2012
- Phage Display of Combinatorial Peptide Libraries: Application to Antiviral ResearchMolecules, 2011
- Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallographyNature, 2010
- Structural changes of envelope proteins during alphavirus fusionNature, 2010
- Expression and Evaluation of Chikungunya Virus E1 and E2 Envelope Proteins for Serodiagnosis of Chikungunya Virus InfectionYonsei Medical Journal, 2008
- AlgPred: prediction of allergenic proteins and mapping of IgE epitopesNucleic Acids Research, 2006
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982